RSA Viewpoints All RSA Viewpoints | Podcasts

Rise of the centenarians

What do increasing life spans and age-related diseases mean for pharma? An industry is forming around human longevity to treat age-related diseases and extend our “health span”. What does this… Read more »

Read more

Twitter

@theRSAgroup

The US FDA has approved Hemgenix, the first gene therapy for the blood-clotting disorder haemophilia B. Its price tag of US$3.5 million makes it the world’s most expensive drug, but it could save the US health-care system millions in the long run.

https://buff.ly/3iQHlcg

Load More